Immunology
Cancer vaccines: not only treating tumors, but preventing them too
The COVID-19 pandemic has brought vaccines back into the drug development spotlight, and mRNA vaccines are stealing the show with […] November 23, 2022 · V-Bio Ventures
New personalized cancer vaccine in the making thanks to unique Belgian collaboration
The young Belgian start-up Persomed is unique – it was founded in 2020 by four partners each with relevant expertise […] November 23, 2022 · BioVoxV-Bio Ventures portfolio company Biodol Therapeutics nominates its first preclinical candidate as a next-generation therapy for neuropathic pain
Ghent, Belgium, 31 August 2022 – V-Bio Ventures portfolio company Biodol Therapeutics, a French biotech company developing next-generation neuropathic pain […] August 31, 2022 · V-Bio VenturesKU Leuven spin-off AstriVax raises € 30 million to build vaccine platform
• Closing on € 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs […] August 25, 2022 · V-Bio Ventures
Dualyx: restoring the body’s balance in autoimmune diseases
Belgian start-up Dualyx is developing a novel approach with the potential to treat a wide range of autoimmune disorders. The […] May 12, 2022 · V-Bio Ventures
miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test
Leuven, Belgium, 2 May 2022 – miDiagnostics, a fast-growing POC diagnostics company announces the launch of its CE-IVD certified ultra-fast COVID-19 PCR […] May 2, 2022 · Turnstone Communications
Abscint labels antibodies with radioactive material to spot harmful cells
Abscint is one of several Belgian biotech companies using single-domain antibodies. But unlike the others, Abscint is using these antibodies […] March 16, 2022 · BioVox
Long COVID: what it means for the life sciences industry and other chronic conditions
Long COVID is a less talked-about aspect of the COVID-19 pandemic, yet its impact on society is already profound. Although […] December 15, 2021 · V-Bio Ventures
Saving kidneys with a test that improves early detection of transplant rejection
All too often, kidney transplants fail because signs of a possible rejection remained unnoticed for too long. That’s why Belgian […] December 15, 2021 · BioVoxNew start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster
Ghent, Belgium, 6 December 2021 – Trince, a spin-off of Ghent University (UGent), is developing innovative and efficient technology to insert […] December 6, 2021 · Turnstone Communications
Confo-dently into the future!
Confo Therapeutics is a rising star in Belgium, featured on several local and international lists of up-and-coming biotechs. The company, […] November 24, 2021 · V-Bio VenturesEsoBiotec ready to transform cell therapy cancer treatments
– EsoBiotec, a recently founded biotech company, announces a EUR 6 million pre-series A round comprised of non-dilutive funding from […] September 30, 2021 · Turnstone Communications
Moderna: from secretive platform company to vaccine superstar
Moderna Therapeutics has never really been a typical biotech. Sure, nowadays it is world famous thanks to its COVID-19 vaccine, […] June 23, 2021 · V-Bio Ventures